88 related articles for article (PubMed ID: 9771960)
1. Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo.
Langdon SP; Rabiasz GJ; Ritchie AA; Reichert U; Buchan P; Miller WR; Smyth JF
Cancer Chemother Pharmacol; 1998; 42(5):429-32. PubMed ID: 9771960
[TBL] [Abstract][Full Text] [Related]
2. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors.
Holmes WF; Dawson MI; Soprano RD; Soprano KJ
J Cell Physiol; 2000 Oct; 185(1):61-7. PubMed ID: 10942519
[TBL] [Abstract][Full Text] [Related]
4. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
5. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437.
Sun SY; Yue P; Shroot B; Hong WK; Lotan R
J Cell Physiol; 1997 Nov; 173(2):279-84. PubMed ID: 9365537
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
Holmes WF; Soprano DR; Soprano KJ
J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293
[TBL] [Abstract][Full Text] [Related]
8. Retinoids and ovarian cancer.
Zhang D; Holmes WF; Wu S; Soprano DR; Soprano KJ
J Cell Physiol; 2000 Oct; 185(1):1-20. PubMed ID: 10942515
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems.
Romanelli S; Perego P; Pratesi G; Carenini N; Tortoreto M; Zunino F
Cancer Chemother Pharmacol; 1998; 41(5):385-90. PubMed ID: 9523734
[TBL] [Abstract][Full Text] [Related]
10. Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway.
Holmes WF; Soprano DR; Soprano KJ
Oncogene; 2003 Sep; 22(41):6377-86. PubMed ID: 14508518
[TBL] [Abstract][Full Text] [Related]
11. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
12. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer.
Macleod K; Mullen P; Sewell J; Rabiasz G; Lawrie S; Miller E; Smyth JF; Langdon SP
Cancer Res; 2005 Aug; 65(15):6789-800. PubMed ID: 16061661
[TBL] [Abstract][Full Text] [Related]
13. Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
Aherne GW; Hardcastle A; Valenti M; Bryant A; Rogers P; Pettit GR; Srirangam JK; Kelland LR
Cancer Chemother Pharmacol; 1996; 38(3):225-32. PubMed ID: 8646796
[TBL] [Abstract][Full Text] [Related]
14. GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells.
Jiang T; Soprano DR; Soprano KJ
J Cell Physiol; 2007 Sep; 212(3):771-9. PubMed ID: 17474084
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid.
Ponzanelli I; Giannì M; Giavazzi R; Garofalo A; Nicoletti I; Reichert U; Erba E; Rambaldi A; Terao M; Garattini E
Blood; 2000 Apr; 95(8):2672-82. PubMed ID: 10753850
[TBL] [Abstract][Full Text] [Related]
17. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells.
Sun SY; Yue P; Lotan R
Oncogene; 2000 Sep; 19(39):4513-22. PubMed ID: 11002424
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells.
Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R
Oncogene; 1999 Apr; 18(14):2357-65. PubMed ID: 10327056
[TBL] [Abstract][Full Text] [Related]
19. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Li D; Williams JI; Pietras RJ
Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
Simpson BJ; Bartlett JM; Macleod KG; Rabiasz G; Miller EP; Rae AL; Gordge P; Leake RE; Miller WR; Smyth J; Langdon SP
Br J Cancer; 1999 Mar; 79(7-8):1098-103. PubMed ID: 10098742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
